Detailed Mechanism Funding and Narrative

Years of mechanism: 2007 2008

Details for Mechanism ID: 5551
Country/Region: Ethiopia
Year: 2008
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $500,000

Funding for Sexual Prevention: Other Sexual Prevention (HVOP): $500,000

Demand Creation and Promotion for Quality

This is a continuing activity. Population Services International (PSI) aims to increase demand for quality HIV

and sexually transmitted infections (STI) prevention services in Ethiopia through social marketing of STI

treatment services that are linked to HIV counseling and testing. The intervention will be supported by

intense service-promotion and demand-creation activities.

In FY06, PSI distributed 50,000 STI (urethral discharge) treatment kits to STI patients through private health

facilities in STI/HIV hotspots in Addis Ababa. In addition, 137 health workers in the private facilities were

trained on STI syndromic management, based on the national guidelines. In FY07, 100,000 kits for the

treatment of urethral discharge and genital ulcers were developed and distributed in private facilities in

STI/HIV hotspots, targeting for most at risk populations (MARPs). These kits contained STI drugs,

promotional materials, partner-notification cards, condoms, HIV testing information, and vouchers to access

free HIV tests. The HIV-testing voucher system increased HIV test uptake.

Kit distribution was accompanied by intense promotion activities to generate demand for quality HIV/STI

services, including HIV testing and treatment services and increased service uptake. Two radio and TV

spots were created and aired, 85 radio advertisements with a generic message on STI and health-seeking

behavior were placed, and 5,000 posters and point-of-sale materials were distributed.

Because of the stigma associated with STI, most STI patients visit lower-level and private facilities. But

private facilities have poor STI reporting and recording systems, and few training opportunities are available

to providers in private facilities. Therefore, in FY08, emphasis will be given to strengthening private facilities

in the areas of STI monitoring by using the STI syndromic approach and STI partner-notification and

management. In addition, the project will procure STI drugs for MARPs for inclusion in the kit. HIV-positive

patients who are either in ART or on palliative care, and who require these treatments, will receive STI

treatment and messaging from this project. The kits will also be used by USAID-supported centers along the

high-risk corridor.

In FY08, PSI will carry out the following major activities in collaboration with the Federal Ministry of Health

(MOH) and regional health bureaus (RHB):

1) Distribution of 150,000 STI treatment kits through private and public facilities, ART clinics, and high risk

corridor centers. The kit is used for the treatment of urethral discharge, genital ulcer, and recurrent genital

ulcer diseases. It is an essential tool for service providers, as it prescribes the correct medication in correct

doses, and provides supporting information, education and communication (IEC) materials and other items

(e.g., condoms).

2) Linkage of STI treatment services to HIV counseling and testing

3) Improvement of service providers in syndromic management through professional training. Emphasis will

be on training identified private-sector providers, though public partners will also be trained.

4) Increased awareness of, and demand for, optimum STI syndromic management services. This will focus

on promotion of good STI services and pre-packaged STI treatment kits.

5) Strengthening and improving STI recording and reporting

6) Strengthening STI partner notification and management